NCT06785532View on ClinicalTrials.gov

Effect of RNS in Treatment-refractory Tourette's Syndrome

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 5, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Tourette Syndrome
Interventions
DEVICE

Responsive Neurostimulation (RNS)

The RNS lead is stereotactically introduced into the target in the brain and fixed to the skull; the lead is then connected to a neurostimulator implanted subcutaneously in the subclavicular region.

Trial Locations (1)

100053

RECRUITING

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER